^Mannocchi G (2020). "Development and validation of fast UHPLC-MS/MS screening method for 87 NPS and 32 other drugs of abuse in hair and nails: application to real cases". Analytical and Bioanalytical Chemistry. 412 (21): 5125–5145.
doi:
10.1007/s00216-020-02462-6.
hdl:11573/1477635.
PMID32062830.
S2CID211128392.
^Freni F (2020). "Determination of fentanyl and 19 derivatives in hair: application to an Italian population". Journal of Pharmaceutical and Biomedical Analysis. 189: 113476.
doi:
10.1016/j.jpba.2020.113476.
PMID32693203.
S2CID220699407.
^Lanzarotta A (2020). "Identification of opioids and related substances using handheld Raman spectrometers". Journal of Forensic Sciences. 65 (2): 421–427.
doi:
10.1111/1556-4029.14217.
PMID31643087.
S2CID204849539.
^Larabi IA (2020). "Development and validation of liquid chromatography-tandem mass spectrometry targeted screening of 16 fentanyl analogs and U-47700 in hair: Application to 137 authentic samples". Drug Testing and Analysis. 12 (9): 1298–1308.
doi:
10.1002/dta.2868.
PMID32476263.
S2CID219172113.
^Strayer KE (2018). "A LC-MS/MS-Based Method for the Multiplex Detection of 24 Fentanyl Analogs and Metabolites in Whole Blood at Sub ng mL-1 Concentrations". {{
cite journal}}: Cite journal requires |journal= (
help)
^Kern S. "Rapid-field-deployable DART-MS screening technique for 87 opioids and drugs of abuse, including fentanyl and fentanyl analogs". Journal of Regulatory Science. 10 (2).
^Garneau B (2021). "A comprehensive analytical process, from NPS threat identification to systematic screening: method validation and one-year prevalence study". Forensic Science International. 318: 110595.
doi:
10.1016/j.forsciint.2020.110595.
PMID33279767.
S2CID227521467.
^Carelli C (2022). "Old and New Synthetic and Semi-synthetic Opioids Analysis in Hair: A Review". Talanta Open. 100108.
Further reading
Higashikawa Y, Suzuki S (June 2008). "Studies on 1-(2-phenethyl)-4-(N-propionylanilino)piperidine (fentanyl) and its related compounds. VI. Structure-analgesic activity relationship for fentanyl, methyl-substituted fentanyls and other analogues". Forensic Toxicology. 26 (1): 1–5.
doi:
10.1007/s11419-007-0039-1.
S2CID22092512.
Alburges ME, Hanson GR, Gibb JW, Sakashita CO, Rollins DE (1992). "Fentanyl receptor assay. II. Utilization of a radioreceptor assay for the analysis of fentanyl analogs in urine". J Anal Toxicol. 16 (1): 36–41.
doi:
10.1093/jat/16.1.36.
PMID1322477.
Woods J, Medzihradsky F, Smith C, Winger G, Gmerek D (1988). "Evaluation of new compounds for opioid activity: 1987 annual report". NIDA Res. Monogr. 81: 543–90.
PMID3136388.
Aceto M, Bowman E, Harris L, May E (1988). "Dependence studies of new compounds in the rhesus monkey, rat, and mouse, 1987". NIDA Res. Monogr. 81: 485–542.
PMID3136386.
^Mannocchi G (2020). "Development and validation of fast UHPLC-MS/MS screening method for 87 NPS and 32 other drugs of abuse in hair and nails: application to real cases". Analytical and Bioanalytical Chemistry. 412 (21): 5125–5145.
doi:
10.1007/s00216-020-02462-6.
hdl:11573/1477635.
PMID32062830.
S2CID211128392.
^Freni F (2020). "Determination of fentanyl and 19 derivatives in hair: application to an Italian population". Journal of Pharmaceutical and Biomedical Analysis. 189: 113476.
doi:
10.1016/j.jpba.2020.113476.
PMID32693203.
S2CID220699407.
^Lanzarotta A (2020). "Identification of opioids and related substances using handheld Raman spectrometers". Journal of Forensic Sciences. 65 (2): 421–427.
doi:
10.1111/1556-4029.14217.
PMID31643087.
S2CID204849539.
^Larabi IA (2020). "Development and validation of liquid chromatography-tandem mass spectrometry targeted screening of 16 fentanyl analogs and U-47700 in hair: Application to 137 authentic samples". Drug Testing and Analysis. 12 (9): 1298–1308.
doi:
10.1002/dta.2868.
PMID32476263.
S2CID219172113.
^Strayer KE (2018). "A LC-MS/MS-Based Method for the Multiplex Detection of 24 Fentanyl Analogs and Metabolites in Whole Blood at Sub ng mL-1 Concentrations". {{
cite journal}}: Cite journal requires |journal= (
help)
^Kern S. "Rapid-field-deployable DART-MS screening technique for 87 opioids and drugs of abuse, including fentanyl and fentanyl analogs". Journal of Regulatory Science. 10 (2).
^Garneau B (2021). "A comprehensive analytical process, from NPS threat identification to systematic screening: method validation and one-year prevalence study". Forensic Science International. 318: 110595.
doi:
10.1016/j.forsciint.2020.110595.
PMID33279767.
S2CID227521467.
^Carelli C (2022). "Old and New Synthetic and Semi-synthetic Opioids Analysis in Hair: A Review". Talanta Open. 100108.
Further reading
Higashikawa Y, Suzuki S (June 2008). "Studies on 1-(2-phenethyl)-4-(N-propionylanilino)piperidine (fentanyl) and its related compounds. VI. Structure-analgesic activity relationship for fentanyl, methyl-substituted fentanyls and other analogues". Forensic Toxicology. 26 (1): 1–5.
doi:
10.1007/s11419-007-0039-1.
S2CID22092512.
Alburges ME, Hanson GR, Gibb JW, Sakashita CO, Rollins DE (1992). "Fentanyl receptor assay. II. Utilization of a radioreceptor assay for the analysis of fentanyl analogs in urine". J Anal Toxicol. 16 (1): 36–41.
doi:
10.1093/jat/16.1.36.
PMID1322477.
Woods J, Medzihradsky F, Smith C, Winger G, Gmerek D (1988). "Evaluation of new compounds for opioid activity: 1987 annual report". NIDA Res. Monogr. 81: 543–90.
PMID3136388.
Aceto M, Bowman E, Harris L, May E (1988). "Dependence studies of new compounds in the rhesus monkey, rat, and mouse, 1987". NIDA Res. Monogr. 81: 485–542.
PMID3136386.